Filing Details
- Accession Number:
- 0001127602-18-010420
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 19:17:02
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-06 19:17:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231845 | Karin Eastham | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-05 | 2,000 | $71.09 | 15,288 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-05 | 260 | $226.80 | 15,028 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-05 | 300 | $227.68 | 14,728 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-05 | 200 | $228.60 | 14,528 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-05 | 700 | $230.17 | 13,828 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-05 | 540 | $230.79 | 13,288 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2018-03-05 | 2,000 | $0.00 | 2,000 | $71.09 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,600 | 2014-05-29 | 2023-05-29 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 260 shares sold ranging from $226.39 to $226.95 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 300 shares sold ranging from $227.50 to $227.90 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 200 shares sold ranging from $228.50 to $228.70 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 700 shares sold ranging from $229.68 to $230.61 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 540 shares sold ranging from $230.70 to $230.87 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
